These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 9614013

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.
    Obaro SK.
    Lancet Glob Health; 2015 Mar; 3(3):e124-5. PubMed ID: 25701988
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hydroxyurea for sickle cell anemia.
    Bachmeyer C, Aractingi S, Lionnet F.
    N Engl J Med; 2008 Jul 03; 359(1):98; author reply 98-9. PubMed ID: 18609755
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease.
    Gille AS, Pondarré C, Dalle JH, Bernaudin F, Chalas C, Fahd M, Jean C, Lezeau H, Riou L, Drouineaud V, Paye-Jaouen A, Kamdem A, Neven B, Arnaud C, Azarnoush S, Yakouben K, Sarnacki S, de Montalembert M, Comperat EM, Lenaour G, Sibony M, Dhédin N, Vaiman D, Wolf JP, Patrat C, Fouchet P, Poirot C, Barraud-Lange V.
    Blood; 2021 Feb 11; 137(6):856-859. PubMed ID: 33259585
    [No Abstract] [Full Text] [Related]

  • 9. [Edifying affair of hydroxycarbamid].
    Nau JY.
    Rev Med Suisse; 2008 Apr 09; 4(152):940. PubMed ID: 18578439
    [No Abstract] [Full Text] [Related]

  • 10. Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia.
    Taylor JG, Darbari DS, Maric I, McIver Z, Arthur DC.
    Ann Intern Med; 2011 Nov 15; 155(10):722-4. PubMed ID: 22084346
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hydroxycarbamide for sickle-cell anaemia in infancy.
    Weatherall DJ.
    Lancet; 2011 May 14; 377(9778):1628-30. PubMed ID: 21571132
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.
    Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi C, James AH, Laraque D, Mendez M, Montoya CJ, Pollock BH, Robinson L, Scholnik AP, Schori M.
    Ann Intern Med; 2008 Jun 17; 148(12):932-8. PubMed ID: 18458271
    [No Abstract] [Full Text] [Related]

  • 15. Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease.
    Brandow AM, Panepinto JA.
    Am J Hematol; 2011 Sep 17; 86(9):804-6. PubMed ID: 21815183
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hydroxyurea in Sickle Cell Disease and Invasive Bacterial Infections: A Case-Control Study.
    Pascault A, Koehl B, Brousse V, Benkerrou M, Gaschignard J.
    J Pediatric Infect Dis Soc; 2024 Sep 26; 13(9):493-495. PubMed ID: 38970408
    [Abstract] [Full Text] [Related]

  • 19. Hydroxyurea therapy contributes to infertility in adult men with sickle cell disease: a review.
    DeBaun MR.
    Expert Rev Hematol; 2014 Dec 26; 7(6):767-73. PubMed ID: 25242414
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.